Home > ASCRS Highlights
    • FILTER YOUR SEARCH
    Speciality:
    More Specialities

    • ASCRS Highlights

    Cataract Surgery
    Liliana Werner, ASCRS 2021: The Femtosecond Laser Intraocular Lens Power Adjustment System

    We were delighted to speak with Liliana Werner (John A Moran Eye Center, University of Utah, Salt Lake City, UT, USA) about preclinical and clinical evidence supporting the use of the femtosecond laser intraocular lens power adjustment system, safety findings to date and the advantages of this technology over existing technologies. Questions: What preclinical and […]

    Cataract Surgery
    Liliana Werner, ASCRS 2021: Intraocular Lens Power Adjustment

    It was a huge pleasure to speak with Liliana Werner (John A Moran Eye Center, University of Utah, Salt Lake City, UT, USA) about intraocular lens power adjustment, focusing on the femtosecond laser intraocular lens power adjustment system and its capabilities. Questions Why do we need to adjust the power of an intraocular lens (IOL) […]

    Cataract Surgery
    David Chang, ASCRS 2021: Antibiotic Prophylaxis – Results from the 2021 ASCRS Member Survey

    We were delighted to speak with our valued Editorial Board member, David Chang (University of California, San Francisco, CA, USA), about the results of the 2021 ASCRS Member Survey on Antibiotic Prophylaxis. Questions In the 2021 ASCRS survey, what percentage of cataract surgeons were using intracameral (IC) antibiotic prophylaxis? (00:12) Which antibiotics were used? (01:02) […]

    Cataract Surgery
    David Chang, ASCRS 2021: Bilateral Cataract Surgery – Benefits and Risks, Patient Selection and Minimizing Complications

    It was a pleasure to catch up with our valued Editorial Board member, David Chang (University of California, San Francisco, CA, USA), who shared his views on the benefits and risks of bilateral cataract surgery, evidence supporting the use of immediate sequential bilateral cataract surgery, as well as his views on factors to be considered […]

    Corneal Disorders
    Sumit Garg, ASCRS 2021: Pterygia – Selection of Adjunctive Modalities and Unmet Needs

    We were delighted to speak with Sumit Garg (Gavin Herbert Eye Institute, University of California, Irvine, CA, USA) about the factors that influence selection of the adjunctive modalities conjunctival autograft, adjunctive amniotic membrane transplantation or intraoperative mitomycin C, for an individual patient, as well as unmet needs and future outlook. Questions What factors influence the […]

    Corneal Disorders
    Sumit Garg, ASCRS 2021: Pterygia – Clinical Characteristics and Surgical Risks

    It was a pleasure to catch up with Sumit Garg (Gavin Herbert Eye Institute, University of California, Irvine, CA, USA), who spoke about the clinical characteristics of pterygium, the risks of surgical removal and improved outcomes from conjunctival autograft, adjunctive amniotic membrane transplantation and intraoperative mitomycin C. Questions Could you give us a brief overview […]

    Cataract Surgery
    Mitchell P Weikert, ASCRS 2021: Managing Expectations for Post-refractive Cataract Surgery Patients

    We were delighted to catch up with Dr Mitchell P Weikert (Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA), who shared his insights on managing expectations in cataract surgery patients who have previously undergone laser-assisted in situ keratomileusis procedures, and tips on optimizing outcomes in these patients. Questions How do you manage expectations […]

    Cataract Surgery
    Mitchell P Weikert, ASCRS 2021: Cataract Surgery on the Post-refractive Eye

    It was a pleasure to interview Dr Mitchell P Weikert (Cullen Eye Institute, Baylor College of Medicine, Houston, TX, USA) about the challenges of cataract surgery in patients who have previously undergone laser-assisted in situ keratomileusis procedures and his recommendation for lenses for post-refractive eyes. Questions What are the challenges of cataract surgery in patients […]

    Ocular Surface Disease
    Jennifer Loh: ASCRS 2020 – A Novel, Targeted, Open Eye, Thermal Therapy for Treatment of Dry Eye

    Jennifer Loh (South Florida Vision Associates, Fort Lauderdale, Florida, USA) discusses unmet needs in the treatment of dry eye, and gives an overview of the TearCare system and the efficacy and safety findings of the OLYMPIA clinical trial. Questions: 1. What are the major unmet needs in the treatment of dry eye? (0:12) 2. Could […]

    Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72